Polypharmacy in older adults with HIV infection: Effects on the brain
J Am Geriatr Soc
.
2022 Mar;70(3):924-927.
doi: 10.1111/jgs.17569.
Epub 2021 Dec 1.
Authors
Lauren Smith
1
,
Scott Letendre
2
,
Kristine M Erlandson
3
,
Qing Ma
4
,
Ronald J Ellis
5
,
Shelli F Farhadian
1
6
Affiliations
1
Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
2
Department of Infectious Diseases, University of California San Diego School of Medicine, San Diego, California, USA.
3
Department of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA.
4
School of Pharmacy & Pharmaceutical Sciences, University of Buffalo, Buffalo, New York, USA.
5
Departments of Neurosciences and Psychiatry, University of California San Diego School of Medicine, San Diego, California, USA.
6
Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
PMID:
34855982
PMCID:
PMC8904273
DOI:
10.1111/jgs.17569
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Aged
Brain
Comorbidity
HIV Infections* / drug therapy
HIV Infections* / epidemiology
Humans
Polypharmacy*
Risk Factors
Grants and funding
R01 AG063659/NH/NIH HHS/United States
R25 MH108389/MH/NIMH NIH HHS/United States
R01 AG054366/NH/NIH HHS/United States
K23 MH118999/MH/NIMH NIH HHS/United States
P30 AG021342/AG/NIA NIH HHS/United States
P30AG02134/NH/NIH HHS/United States
R01 AG063659/AG/NIA NIH HHS/United States
K23MH118999/NH/NIH HHS/United States
P30 MH062512/MH/NIMH NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States
T32AG019134/NH/NIH HHS/United States